Product NDC: | 0074-2458 |
Proprietary Name: | MERIDIA |
Non Proprietary Name: | sibutramine hydrochloride |
Active Ingredient(s): | 15 mg/1 & nbsp; sibutramine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0074-2458 |
Labeler Name: | Abbott Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020632 |
Marketing Category: | NDA |
Start Marketing Date: | 20100812 |
Package NDC: | 0074-2458-11 |
Package Description: | 30 CAPSULE in 1 BOTTLE (0074-2458-11) |
NDC Code | 0074-2458-11 |
Proprietary Name | MERIDIA |
Package Description | 30 CAPSULE in 1 BOTTLE (0074-2458-11) |
Product NDC | 0074-2458 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sibutramine hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20100812 |
Marketing Category Name | NDA |
Labeler Name | Abbott Laboratories |
Substance Name | SIBUTRAMINE HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Appetite Suppression [PE],Dopamine Uptake Inhibitors [MoA],Norepinephrine Uptake Inhibitors [MoA],Norepinephrine, Serotonin, and Dopamine Reuptake Inhibitor Anorectic [EPC],Serotonin Uptake Inhibitors [MoA] |